Clinical Trial Update: Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

View source ↗

Summary

The COMPPASS registry study by Precia Group aims to comprehensively monitor outcomes for peri- and postnatal invasive Group B Streptococcus sequelae, with statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Early-onset Group Streptococcal Disease
• Group Streptococcal Infection
• Invasive Group Streptococcal Disease
• Late-onset Group Streptococcal Disease

Snippet

Sponsor: Precia Group | Conditions: Invasive Group B Streptococcus Disease, Group B Streptococcus | Status: NOT_YET_RECRUITING